{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifrmpcujvqzj3po56h6ouxj75wt76s73p7mtdl47k4pwjnljap7ci",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3merb3bbgl5c2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifusyx7gxqi3bfdqlmfdzxtqkil4gf2oqaia7hbpp5goyrtaqqv2y"
    },
    "mimeType": "image/jpeg",
    "size": 154693
  },
  "path": "/news/2026-02-false-alarm-newborn-screening-zebrafish.html",
  "publishedAt": "2026-02-13T14:20:01.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Genetics"
  ],
  "textContent": "A positive newborn screening for spinal muscular atrophy (SMA) is currently considered a medical emergency. Without early treatment, severe disability or death in infancy are likely. However, research findings from Germany and Australia now show that in rare cases, a positive screening result can be a genetic false alarm. Researchers have discovered that functional tests in a zebrafish model may enable fast and reliable clinical decision-making in cases of unclear genetic findings.",
  "title": "False alarm in newborn screening: How zebrafish can prevent unnecessary spinal muscular atrophy therapies"
}